Diversity of vertebrate nicotinic acetylcholine receptors.
about
Multiple roles for nicotine in Parkinson's diseaseNovel structural determinants of single channel conductance and ion selectivity in 5-hydroxytryptamine type 3 and nicotinic acetylcholine receptorsEmerging preclinical pharmacological targets for Parkinson's diseaseNicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug useConotoxin Interactions with α9α10-nAChRs: Is the α9α10-Nicotinic Acetylcholine Receptor an Important Therapeutic Target for Pain Management?In utero and Lactational Exposure to Acetamiprid Induces Abnormalities in Socio-Sexual and Anxiety-Related Behaviors of Male MiceNMR structure of the transmembrane domain of the n-acetylcholine receptor β2 subunitNicotinic receptor modulation to treat alcohol and drug dependenceFunctional probes of drug-receptor interactions implicated by structural studies: Cys-loop receptors provide a fertile testing groundPhylogenomics of ligand-gated ion channels predicts monepantel effectContrasting properties of α7-selective orthosteric and allosteric agonists examined on native nicotinic acetylcholine receptorsChemical chaperones exceed the chaperone effects of RIC-3 in promoting assembly of functional α7 AChRsUnexpected effects of low doses of a neonicotinoid insecticide on behavioral responses to sex pheromone in a pest insectEscherichia coli Protein Expression System for Acetylcholine Binding Proteins (AChBPs)Functional and Biochemical Characterization of Alvinella pompejana Cys-Loop Receptor HomologuesNicotinic receptors in the dorsal and ventral hippocampus differentially modulate contextual fear conditioning.Functional expression of human α9* nicotinic acetylcholine receptors in X. laevis oocytes is dependent on the α9 subunit 5' UTR.The effects of galantamine on nicotine withdrawal-induced deficits in contextual fear conditioning in C57BL/6 mice.The enhancement of contextual fear conditioning by ABT-418.The Concise Guide to PHARMACOLOGY 2013/14: ligand-gated ion channels.Engineering neuronal nicotinic acetylcholine receptors with functional sensitivity to alpha-bungarotoxin: a novel alpha3-knock-in mouse.Nicotinic mechanisms influencing synaptic plasticity in the hippocampus.Intracranial self-stimulation to evaluate abuse potential of drugs.Activation and inhibition of mouse muscle and neuronal nicotinic acetylcholine receptors expressed in Xenopus oocytes.A fungal metabolite asperparaline a strongly and selectively blocks insect nicotinic acetylcholine receptors: the first report on the mode of actionAlpha-conotoxin AuIB isomers exhibit distinct inhibitory mechanisms and differential sensitivity to stoichiometry of alpha3beta4 nicotinic acetylcholine receptors.Neurobiological mechanisms involved in nicotine dependence and reward: participation of the endogenous opioid system.The α3β4* nicotinic ACh receptor subtype mediates physical dependence to morphine: mouse and human studies.Role for the nicotinic cholinergic system in movement disorders; therapeutic implications.Changes in temperature have opposing effects on current amplitude in α7 and α4β2 nicotinic acetylcholine receptors.The α7 nicotinic receptor agonist ABT-107 decreases L-Dopa-induced dyskinesias in parkinsonian monkeysNicotinic receptors on rat alveolar macrophages dampen ATP-induced increase in cytosolic calcium concentration.Nicotine as a potential neuroprotective agent for Parkinson's disease.Cysteine accessibility analysis of the human alpha7 nicotinic acetylcholine receptor ligand-binding domain identifies L119 as a gatekeeperBiosynthesis of ionotropic acetylcholine receptors requires the evolutionarily conserved ER membrane complex.α9-nicotinic acetylcholine receptors contribute to the maintenance of chronic mechanical hyperalgesia, but not thermal or mechanical allodynia.Neuronal nicotinic acetylcholine receptors: common molecular substrates of nicotine and alcohol dependence.Tethered agonist analogs as site-specific probes for domains of the human α7 nicotinic acetylcholine receptor that differentially regulate activation and desensitization.Nicotinic acetylcholine receptor and the structural basis of neuromuscular transmission: insights from Torpedo postsynaptic membranesNicotinic receptor antagonists as treatments for nicotine abuse.
P2860
Q22252514-95DB437F-E908-4A3F-86C5-F53DCB31B576Q24642653-705A989A-4250-4C67-AC6A-7A7873A88FB1Q26764724-B18E97BE-5BA7-4BF5-9E67-F39D2C342FDEQ26782271-10255991-4B71-44D1-8D59-201D74D2C78DQ26783037-148055DD-834B-4569-B716-793009CA3667Q27312307-0149AD5C-65C4-4081-86CC-444954A2A5BFQ27661310-D008ECB1-925D-4101-80F9-31402DEB6863Q28087047-D5A31BC0-8DCA-4283-A7B6-0940F4DAB452Q28307979-CF8D34D1-941E-47DE-A0FF-13B76D060FBFQ28475454-90025A61-4326-4122-BFDC-727DE26A00D2Q28485342-18C53BCD-8061-44BE-B0F5-A4A15FBB91C9Q28486758-79019223-9306-4986-A365-A9DF5B2DF28AQ28542733-81443F77-74D7-44BA-A69B-64776CCDBA7AQ28550270-035F9A3D-774B-4EBB-AC3D-5C7F85378490Q28550915-5456EA91-BEAB-455D-BB7B-8890FB927AB9Q30451446-682920E8-9B95-4404-9689-C5F8423AFBC5Q30454356-7E38E045-F037-44CF-AC8D-F46D9EB67A34Q30463325-71A4BDDA-BC2B-456D-A707-F55968AA20BFQ30475610-2C39FD70-D421-4554-ABF3-8840A4139DD0Q30486732-D0DB53CD-97CF-467B-AA6D-ED4EFE411DF6Q33636887-A3970A8F-31F1-44ED-BA69-C75FF2F898FEQ33830478-8605BB57-318E-4A89-BD92-D184508F0122Q33845750-3DC1B008-B313-49BF-8491-B1401131EBF5Q33861982-56484D88-7B4C-4B66-8BC5-3EB0AB9F85EBQ33869543-A2C1971C-CBA3-4C77-9DD0-B2A0459CEE1FQ33991060-FAC4FD41-0C87-477F-ADDA-99A342C4B9BCQ34012381-DF297231-6102-4DD0-B5F1-2B5CE68CED80Q34025082-308AD9DB-0C6A-47E7-A926-687BEA8F1D78Q34112026-6D35145C-3CC8-4E7F-8DAD-0C9868DBE9FDQ34168556-B1706678-34B9-422F-B2A0-CC57AD7BD03FQ34186299-12C5BB6E-E858-4713-BC91-E0F6D7346591Q34203150-D42D4B0A-FBA8-4E21-91A3-E910D65868EDQ34281003-30277E0E-0455-46F1-B1B7-461DC47A4BF0Q34311383-CD4790A0-D097-4EB3-B927-D5FEA9816398Q34329117-A7EAEE60-0EDB-4014-9048-42870FC11405Q34333395-D5CA1957-A326-4F9C-B626-F56DF477CF77Q34342747-9414777F-BA42-40E9-84F9-279FCEC9E008Q34359550-48DC2964-382C-4EE0-A93A-09DBBD74D847Q34372276-6C239F30-14E8-45E4-8DD0-7518BBDFCD7FQ34401397-F49F4D2E-FB7C-4010-8C11-55ABDD0DB329
P2860
Diversity of vertebrate nicotinic acetylcholine receptors.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Diversity of vertebrate nicotinic acetylcholine receptors.
@ast
Diversity of vertebrate nicotinic acetylcholine receptors.
@en
Diversity of vertebrate nicotinic acetylcholine receptors.
@nl
type
label
Diversity of vertebrate nicotinic acetylcholine receptors.
@ast
Diversity of vertebrate nicotinic acetylcholine receptors.
@en
Diversity of vertebrate nicotinic acetylcholine receptors.
@nl
prefLabel
Diversity of vertebrate nicotinic acetylcholine receptors.
@ast
Diversity of vertebrate nicotinic acetylcholine receptors.
@en
Diversity of vertebrate nicotinic acetylcholine receptors.
@nl
P1433
P1476
Diversity of vertebrate nicotinic acetylcholine receptors.
@en
P2093
Cecilia Gotti
Neil S Millar
P304
P356
10.1016/J.NEUROPHARM.2008.07.041
P577
2008-08-05T00:00:00Z